Article
Emerging Biomarkers in Thyroid Practice and Research
31 Dec 2021
Abstract excerpt
Thyroid cancer is the most common endocrine malignancy. Recent developments in molecular biological techniques have led to a better understanding of the pathogenesis and clinical behavior of thyroid neoplasms. This has culminated in the updating of thyroid tumor classification, including the re-categorization of existing and introduction of new entities. In this review, we discuss various molecular biomarkers...
Topics
Join the communities discussing this publication.